CLOVIS ONCOLOGY INC - COM (CLVSQ)

Historical Holders from Q1 2014 to Q4 2023

Symbol
CLVSQ
Type / Class
Equity / COM
All holders as of 31 Dec 2023
Q4 2023
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2023 Q4 0 $0 -$11,008 0
2023 Q3 229 $11,008 +$11,008 $48.07 1
2023 Q2 0 $0 -$520,176 0
2023 Q1 36,795 $520,176 -$19,039 $15.48 2
2022 Q4 399,191 $499,094 -$41,909,415 $0.052 11
2022 Q3 35,602,287 $42,385,329 -$8,922,478 $1.19 88
2022 Q2 42,069,711 $75,701,107 -$23,572,653 $1.8 101
2022 Q1 55,101,964 $111,298,078 -$22,169,179 $2.02 136
2021 Q4 65,128,864 $176,503,793 +$10,344,308 $2.71 140
2021 Q3 61,381,279 $273,753,545 +$25,683,517 $4.46 144
2021 Q2 55,107,197 $319,615,726 +$33,772,157 $5.8 150
2021 Q1 49,081,412 $344,521,272 -$24,975,036 $7.02 154
2020 Q4 54,672,036 $262,464,060 +$16,481,166 $4.8 150
2020 Q3 50,733,997 $295,822,953 +$31,944,283 $5.83 160
2020 Q2 45,474,457 $306,947,921 +$87,072,837 $6.75 150
2020 Q1 32,969,181 $209,668,642 -$28,534,920 $6.36 141
2019 Q4 34,312,092 $357,708,058 -$97,449,312 $10.43 145
2019 Q3 50,833,537 $199,809,587 -$59,641,815 $3.93 145
2019 Q2 50,589,979 $751,662,511 -$57,403,173 $14.87 162
2019 Q1 49,852,215 $1,237,313,191 -$83,234,510 $24.82 184
2018 Q4 53,369,776 $958,514,173 -$149,964,792 $17.96 157
2018 Q3 55,439,550 $1,628,256,106 +$3,161,123 $29.37 188
2018 Q2 54,275,200 $2,467,994,101 +$187,598,988 $45.47 208
2018 Q1 49,875,767 $2,633,455,707 -$110,127,754 $52.8 224
2017 Q4 51,414,850 $3,496,341,436 +$19,380,879 $68 245
2017 Q3 50,420,278 $4,153,720,447 +$104,247,286 $82.4 254
2017 Q2 48,591,010 $4,549,304,701 +$527,641,675 $93.63 267
2017 Q1 43,907,306 $2,795,534,091 +$580,474,285 $63.67 227
2016 Q4 37,800,348 $1,679,080,419 -$51,120,627 $44.42 165
2016 Q3 39,155,692 $1,411,080,174 +$68,928,902 $36.05 161
2016 Q2 38,175,896 $523,888,375 -$18,520,051 $13.72 118
2016 Q1 37,570,941 $721,322,587 -$62,306,470 $19.2 133
2015 Q4 39,851,262 $1,394,741,115 -$69,062,329 $35 153
2015 Q3 35,564,895 $3,270,421,904 +$311,576,416 $91.96 189
2015 Q2 32,286,992 $2,836,966,493 -$8,635,322 $87.88 176
2015 Q1 32,452,015 $2,408,764,108 -$37,574,515 $74.23 151
2014 Q4 33,146,040 $1,855,800,320 +$185,085,907 $56 141
2014 Q3 28,863,350 $1,308,782,704 +$55,156,732 $45.36 137
2014 Q2 27,867,489 $1,153,296,718 -$8,153,130 $41.41 140
2014 Q1 26,975,785 $1,868,642,481 +$126,824,174 $69.27 135